Jeevan Scientific Technology Ltd538837Corporate

Healthcare Research, Analytics & Technology Latest results: Jun 2026 14 quarters of data

₹79.71

MCap ₹178 Cr · P/E 34.7

Jeevan Scientific Technology Ltd — Stock analysis & AI research Jeevan Scientific Technology Ltd — Multibagger AI analysis Jeevan Scientific Technology Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹18 Cr

Sales · Jun 2026

+107.7% YoY

₹3 Cr

Operating Profit · Jun 2026

+265.9% YoY

16.2%

OPM % · Jun 2026

+180.2% YoY

₹1 Cr

Net Profit · Jun 2026

+127.0% YoY

—

EPS · Jun 2026

📝 Jeevan Scientific Technology Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Jeevan Scientific Technology Ltd reported revenue of ₹18 crore for the quarter ended June 2026 (Q1 FY27), up 107.7% from ₹9 crore in the same quarter last year, and down 14.1% sequentially over the March 2026 quarter.

The company swung to a net profit of ₹1 crore from a net loss of ₹3 crore a year earlier.

Operating profit stood at ₹3 crore — an operating margin (OPM) of 16.2%, compared with -20.2% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Jeevan Scientific Technology Ltd posted revenue of ₹62 crore, a growth of 31.4% over FY25, with a net profit of ₹1 crore (up 1371.4% year-on-year).

On a trailing-twelve-month (TTM) basis, revenue stands at ₹71 crore with a net profit of ₹5 crore.

Valuation snapshot

At the current price of ₹79.71, 538837 has a market capitalisation of ₹178 crore and a trailing P/E of about 34.7.

Within the Healthcare Research, Analytics & Technology industry, it is the 8th-largest of the 10 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 30.25%, public shareholders 69.75% of Jeevan Scientific Technology Ltd.

Promoter holding slipped from 38.05% to 30.25% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹178 Cr

Current Price ?

₹79.7

P/E ?

34.72below ind

Industry P/E ?

35.60

P/B ?

2.47

P/S ?

2.50

P/FCF ?

-22.91

Enterprise Value ?

₹199 Cr

EV/EBITDA ?

13.69

PEG ?

1.05

Earnings Yield ?

4.0%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹71 Cr

OPM ?

20.5%

Profit after tax (TTM) ?

₹5 Cr

EPS (TTM) ?

₹2.30

ROCE ?

5.0%

ROE ?

7.1%

ROA ?

4.8%

Growth

Sales — latest qtr ?

₹18 Cr

PAT — latest qtr ?

₹1 Cr

YoY qtr sales growth ?

107.7%

YoY qtr profit growth ?

127.0%

Sales growth (3y) ?

19%

Sales growth (5y) ?

Profit growth (3y) ?

33%

Profit growth (5y) ?

-37%

Financial Health

Debt ?

₹21 Cr

Debt to Equity ?

0.30

Interest Coverage ?

1.6

Current Ratio ?

N/A

Ownership

Promoter holding ?

30.25%

Change in promoter holding ?

-7.80%

Pledged percentage ?

N/A

Market

Return 3 months ?

-0.4%

Return 6 months ?

20.5%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	8	10	8	10	11	13	11	13	10	9	12	19	21	18	+107.7%	-14.1%
Operating Profit	-1	2	1	1	1	3	2	2	-0	-2	2	5	4	3	+265.9%	-31.2%
Other Income	0	0	0	-0	0	0	0	0	0	0	0	0	0	0	-47.2%	-39.9%
Interest	0	0	0	0	0	0	0	0	1	1	1	1	0	0	-18.4%	+7.5%
Depreciation	1	1	1	1	2	2	1	1	2	2	2	2	2	2	-2.1%	+5.8%
Profit Before Tax	-2	1	-1	-1	-1	2	1	0	-3	-4	0	3	3	1	+126.2%	-61.9%
Net Profit	-2	1	-1	-0	-1	1	0	0	-1	-3	0	2	2	1	+127.0%	-52.7%
EPS	-1.49	0.34	-0.39	-0.31	-0.47	0.70	0.16	0.07	-0.82	-1.96	-0.06	0.90	0.81	—	—	—
OPM %	-13.0%	19.5%	7.4%	10.0%	8.9%	25.1%	21.9%	16.5%	-3.8%	-20.2%	16.7%	27.4%	20.2%	16.2%	+180.2%	-19.8%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹47 Cr	₹62 Cr	₹71 Cr	+31.4%
Operating Profit	₹7 Cr	₹10 Cr	₹15 Cr	+32.2%
OPM %	15.84%	15.94%	20.48%	+0.6%
NPM %	0.15%	1.67%	7.21%	+1013.3%
Other Income	₹1 Cr	₹1 Cr	₹1 Cr	+47.7%
Depreciation	₹6 Cr	₹7 Cr	₹7 Cr	+6.2%
Interest	₹2 Cr	₹2 Cr	₹2 Cr	+15.9%
EBIT	₹1 Cr	₹3 Cr	₹8 Cr	+170.9%
PBT	₹0 Cr	₹2 Cr	₹7 Cr	+3383.3%
Tax	—	—	₹-0 Cr	—
Net Profit	₹0 Cr	₹1 Cr	₹5 Cr	+1371.4%
EPS	₹0.11	₹-0.31	₹1.65	-381.8%
Material Cost	—	—	₹2 Cr	—
Employee Cost	—	—	₹6 Cr	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	15.48	15.48	15.83	19.92	+25.8%
Reserves	32.71	32.95	34.11	52.02	+52.5%
Borrowings	10.10	13.41	20.58	21.28	+3.4%
Other Liabilities	7.63	6.03	7.77	13.37	+72.1%
Total Liabilities	65.92	67.87	78.29	106.59	+36.1%
Fixed Assets	24.97	26.66	34.55	36.08	+4.4%
CWIP	1.90	2.81	4.71	4.71	+0.0%
Investments	0.00	0.00	0.00	2.98	—
Other Assets	39.05	38.40	39.03	62.82	+61.0%
Total Assets	65.92	67.87	78.29	106.59	+36.1%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	-6.41	2.89	10.07	0.42	-95.8%
Cash from Investing Activity	-6.93	-11.53	-15.62	-9.98	+36.1%
Cash from Financing Activity	-9.54	2.35	5.24	18.83	+259.4%
Net Cash Flow	-22.88	-6.29	-0.30	9.26	+3186.7%
Free Cash Flow	-14.57	-9.14	-5.96	-7.76	-30.2%
CFO/OP	-269%	101%	135%	5%	-96.3%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	117.83	113.14	124.21	122.71	-1.2%
Inventory Days	105.50	104.15	155.61	226.63	+45.6%
Days Payable	322.56	205.43	305.45	458.49	+50.1%
Cash Conversion Cycle	-99.23	11.85	-25.63	-109.15	-325.9%
Working Capital Days	110.67	137.35	128.19	121.41	-5.3%
ROCE %	-4.34%	-1.03%	2.80%	5.01%	+78.9%

👥 Shareholding (latest 4 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	% Chg
Promoters	38.05%	38.05%	38.05%	30.25%	-20.5%
Public	61.96%	61.95%	61.96%	69.75%	+12.6%
No. of Shareholders	5,460	5,444	5,159	5,053	-2.1%

⚖️ Peer comparison

Industry: Healthcare Research, Analytics & Technology · 10 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	INDGN Indegene	₹597.05	14,377	35.8	3,812	401	16.7%	10.5%	23.6%	-1.5%	39.7%	-0.2%
2	SUVEN Suven Life	₹286.25	8,088	—	9	-353	-3955.0%	-3815.2%	6.9%	-71.9%	114.3%	-148.5%
3	VIMTALABS Vimta Labs	₹637.20	2,847	35.7	419	80	34.4%	19.1%	18.0%	19.5%	11.3%	10.7%
4	FABTECH Fabtech Technologies	₹145.66	647	44.8	364	14	2.4%	4.0%	—	—	10.3%	168.7%
5	526853 Bilcare Ltd-$	₹61.25	215	—	773	-6	9.1%	-0.8%	-6.9%	36.7%	21.2%	253.4%
6	TAKE Take Solutions	₹12.69	186	14.6	85	13	-2.0%	15.2%	—	-71.0%	—	216.8%
7	536565 Novelix Pharmaceuticals	₹19.88	181	13.2	147	4	3.1%	2.5%	330.7%	2218.2%	65.2%	971.7%
8	538837 Jeevan Scientific	₹50.96	178	22.6	71	5	20.5%	7.2%	31.4%	1371.4%	107.7%	127.0%
9	543309 Adeshwar Meditex	₹27.50	24	31.2	56	1	4.9%	2.2%	—	—	-30.4%	-60.4%
10	540729 Vanta Bioscience	₹51.45	15	333.1	2	0	55.8%	6.1%	—	—	357.6%	240.9%

❓ Frequently asked questions

What was Jeevan Scientific Technology Ltd's revenue in Q1 FY27?

What was Jeevan Scientific Technology Ltd's net profit in Q1 FY27?